William Cacini

558 total citations
28 papers, 463 citations indexed

About

William Cacini is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, William Cacini has authored 28 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in William Cacini's work include Chemotherapy-induced organ toxicity mitigation (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). William Cacini is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). William Cacini collaborates with scholars based in United States. William Cacini's co-authors include Bellamkonda Kishore, Arthur R. Buckley, Rangaprasad Sarangarajan, Donna J. Buckley, Steven A. Myre, Carissa M. Krane, Anil G. Menon, David Sheikh‐Hamad, Luan D. Truong and Chun C. Tsao and has published in prestigious journals such as Kidney International, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

William Cacini

28 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Cacini United States 12 144 137 128 89 67 28 463
Tawfeeg A. Najjar Saudi Arabia 14 144 1.0× 241 1.8× 146 1.1× 52 0.6× 54 0.8× 26 726
J J Lima United States 18 161 1.1× 39 0.3× 80 0.6× 78 0.9× 154 2.3× 35 707
Mitsutaka Kanamaru Japan 15 140 1.0× 48 0.4× 97 0.8× 42 0.5× 71 1.1× 44 698
Blanca Humanes Spain 10 121 0.8× 200 1.5× 69 0.5× 66 0.7× 49 0.7× 15 545
C Josepovitz United States 14 208 1.4× 44 0.3× 133 1.0× 63 0.7× 24 0.4× 17 535
Kazuko Sagawa United States 15 356 2.5× 56 0.4× 149 1.2× 100 1.1× 73 1.1× 29 743
Inger Holmberg Sweden 19 152 1.1× 404 2.9× 74 0.6× 80 0.9× 41 0.6× 27 808
A. McBurney United Kingdom 16 156 1.1× 29 0.2× 51 0.4× 75 0.8× 68 1.0× 38 679
Satoru Nagashima Japan 15 135 0.9× 26 0.2× 66 0.5× 41 0.5× 40 0.6× 41 565
Adnan El‐Yazigi Saudi Arabia 15 94 0.7× 51 0.4× 97 0.8× 64 0.7× 59 0.9× 60 597

Countries citing papers authored by William Cacini

Since Specialization
Citations

This map shows the geographic impact of William Cacini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Cacini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Cacini more than expected).

Fields of papers citing papers by William Cacini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Cacini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Cacini. The network helps show where William Cacini may publish in the future.

Co-authorship network of co-authors of William Cacini

This figure shows the co-authorship network connecting the top 25 collaborators of William Cacini. A scholar is included among the top collaborators of William Cacini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Cacini. William Cacini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarangarajan, Rangaprasad & William Cacini. (2004). Early Onset of Cisplatin‐Induced Nephrotoxicity in Streptozotocin‐Diabetic Rats Treated with Insulin*. Basic & Clinical Pharmacology & Toxicology. 95(2). 66–71. 8 indexed citations
2.
Buckley, Donna J., et al.. (2004). Reduced Expression of Organic Cation Transporters rOCT1 and rOCT2 in Experimental Diabetes. Journal of Pharmacology and Experimental Therapeutics. 308(3). 949–956. 59 indexed citations
3.
Sheikh‐Hamad, David, William Cacini, Arthur R. Buckley, et al.. (2004). Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Archives of Toxicology. 78(3). 147–155. 73 indexed citations
4.
Sarangarajan, Rangaprasad, et al.. (2002). Functional Impairment of Renal Organic Cation Transport in Experimental Diabetes. Pharmacology & Toxicology. 90(4). 181–186. 29 indexed citations
5.
Ecelbarger, Carolyn, Jeff M. Sands, John Doran, William Cacini, & Bellamkonda Kishore. (2001). Expression of salt and urea transporters in rat kidney during cisplatin-induced polyuria. Kidney International. 60(6). 2274–2282. 34 indexed citations
6.
Kishore, Bellamkonda, et al.. (2000). Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney International. 58(2). 701–711. 68 indexed citations
7.
Sarangarajan, Rangaprasad & William Cacini. (1999). Normalization of Hyperglycaemia by Oral Vanadyl Sulfate Does Not Reverse Diabetes‐Induced Protection against Cisplatin Nephrotoxicity in Streptozotocin‐Diabetic Rats. Pharmacology & Toxicology. 85(6). 169–173. 1 indexed citations
8.
Cacini, William, et al.. (1997). Diabetes‐Induced Protection from Cisplatin Nephrotoxicity is Associated with Impairment of Energy‐Dependent Uptake by Renal Cortex Slices. Pharmacology & Toxicology. 81(4). 197–198. 9 indexed citations
9.
Tang, Xia, et al.. (1997). Determination of Biotransformation Products of Platinum Drugs in Rat and Human Urine. Metal-Based Drugs. 4(2). 97–109. 11 indexed citations
10.
Tan, Henry S.I., et al.. (1996). High performance liquid chromatographic assay of amprolium and ethopabate in chicken feed using solid-phase extraction. Journal of Pharmaceutical and Biomedical Analysis. 15(2). 259–265. 18 indexed citations
11.
Sarangarajan, Rangaprasad & William Cacini. (1996). Effect of Route of Administration and Dose on Diabetes-Induced Protection against Cisplatin Nephrotoxicity. Experimental Biology and Medicine. 212(4). 362–368. 12 indexed citations
12.
Cacini, William, et al.. (1995). Toxicity and excretion of cisplatin in the avian kidney. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 111(2). 343–350. 1 indexed citations
13.
Cacini, William, et al.. (1993). Reduced Renal Accumulation and Toxicity of Cisplatin in Experimental Galactosemia. Experimental Biology and Medicine. 203(3). 348–353. 12 indexed citations
14.
Cacini, William & Yash Pal Singh. (1991). Renal Metallothionein and Platinum Levels in Diabetic and Nondiabetic Rats Injected with Cisplatin. Experimental Biology and Medicine. 197(3). 285–289. 10 indexed citations
15.
Cacini, William, et al.. (1990). Concentrative uptake of digoxin by slices of chicken renal cortex. Biochemical Pharmacology. 39(4). 655–659. 2 indexed citations
16.
Ritschel, W. A., et al.. (1985). Animal model for theophylline--cimetidine drug interaction.. PubMed. 7(12). 627–9. 4 indexed citations
17.
Cacini, William. (1982). Comparative accumulation of uric acid and hypoxanthine by slices of avian renal cortex.. Journal of Pharmacology and Experimental Therapeutics. 220(1). 86–90. 3 indexed citations
18.
First, M. Roy, et al.. (1982). Effect of Co-trimoxazole and Sulfamethoxazole on Serum Creatinine in Normal Subjects. Therapeutic Drug Monitoring. 4(1). 77–80. 26 indexed citations
19.
Cacini, William & W. A. Ritschel. (1980). The excretion of coumarin and hydroxycoumarins by the avian kidney in vivo.. PubMed. 243(2). 197–208. 1 indexed citations
20.
Cacini, William & A J Quebbemann. (1978). The metabolism and active excretion of the hypoxanthine by the renal tubules in the chicken.. Journal of Pharmacology and Experimental Therapeutics. 207(2). 574–583. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tawfeeg A. Najjar Breakdown of academic impact, for papers by J J Lima Breakdown of academic impact, for papers by Mitsutaka Kanamaru Breakdown of academic impact, for papers by Blanca Humanes Breakdown of academic impact, for papers by C Josepovitz Breakdown of academic impact, for papers by Kazuko Sagawa Breakdown of academic impact, for papers by Inger Holmberg Breakdown of academic impact, for papers by A. McBurney Breakdown of academic impact, for papers by Satoru Nagashima Breakdown of academic impact, for papers by Adnan El‐Yazigi
Rankless by CCL
2026